Regulator Spotlight
During the extended Q&A that concluded the regulatory session at the June 2025 CASSS CGTP Symposium, regulators from Italy, The Netherlands, Japan, Canada, and Spain shed further light on the issues and initiatives their respective agencies are engaged with at the national and international level to support cell and gene therapy development. Also participating in the Q&A was a former U.S. FDA CGT regulator.
CLICK HERE to view the issue.
ABOUT THE WEEKLY SUPPLEMENT
Along with a feature story on a presentation or panel discussion in which regulatory agency and pharmacopeia leaders address the challenges and developments in a key area of concern, our Weekly Supplements include a summary listing of the “Updates in Brief,” drug GMP warning letters and recalls, and EMA non-compliance reports that have been posted on IPQ’s website during the week. Subscribers can then click through to the full posting.
Also provided, where applicable, are links to the parts of in-depth stories and Monthly Updates that have been released during the week.
Appended to the issue is a chronological listing of the headlines of the featured regulator stories since IPQ began its Weekly Supplement series in February 2024. Also appended are the headlines of the in-depth stories that IPQ has released since 2020. Those of especially high relevance to the regulator insights provided in this issue are indicated with a red star. Click on the headlines to access the stories.